[Results of the treatment of patients with atypical sarcoidosis of the respiratory organs].
Efficacy of treatment, including its immediate and longterm outcomes, in 109 patients with atypical respiratory sarcoidosis were analysed. The treatment regimens were as follows: corticosteroid hormones supplemented by delagil and vitamin E, intermittent corticosteroid therapy, administration of long-acting++ corticosteroid hormones and treatment with presocyl, delagil and vitamin E. Due to the given treatment, a favourable clinical effect was achieved in 74.3% of the cases with the process remaining stable in 2.8% and recurrent development of the disease in 22.9%. Persistent favourable outcomes in a distant future were registered in 82.9%, stable process--in 3.9%, and progression with aggravation and relapses--in 13.2% of the patients.
Teriaeva
M V
MV
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D002738:Chloroquine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008199:Lymphadenitis / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage; D011859:Radiography; D012507:Sarcoidosis / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D014810:Vitamin E / Q000008:administration & dosage
D000893:Anti-Inflammatory Agents; D014810:Vitamin E; C023676:chloroquine diphosphate; D002738:Chloroquine; D011239:Prednisolone
Rezul'taty lecheniia bol'nykh s atipichnym sarkoidozom organov dykhaniia.